Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: AMD and IBM Detail Early Results Using Immersion and Ultra Low-K in 45nm Chips

AMD and IBM Detail Early Results Using Immersion and Ultra Low-K in 45nm Chips

posted on Dec 12, 2006 01:58AM
December 12, 2006 06:01 AM Eastern Time

AMD and IBM Detail Early Results Using Immersion and Ultra Low-K in 45nm Chips

Advanced Technologies Provide Improved Performance and Efficiency While Reducing Complexity in Microprocessor Design and Manufacturing

Contacts

AMD
Jon Carvill, (512) 602-0499 (PR)
jon.carvill@amd.com
or
Mike Haase, 408-749-3124 (IR)
or
IBM
Glen Brandow, 914-766-4615 (PR)
brandow@us.ibm.com

Share
New Message
Please login to post a reply